BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14717962)

  • 1. What the structure of angiostatin may tell us about its mechanism of action.
    Geiger JH; Cnudde SE
    J Thromb Haemost; 2004 Jan; 2(1):23-34. PubMed ID: 14717962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The X-ray crystallographic structure of the angiogenesis inhibitor angiostatin.
    Abad MC; Arni RK; Grella DK; Castellino FJ; Tulinsky A; Geiger JH
    J Mol Biol; 2002 May; 318(4):1009-17. PubMed ID: 12054798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiangiogenic kringles derived from human plasminogen and apolipoprotein(a) inhibit fibrinolysis through a mechanism that requires a functional lysine-binding site.
    Ahn JH; Lee HJ; Lee EK; Yu HK; Lee TH; Yoon Y; Kim SJ; Kim JS
    Biol Chem; 2011 Apr; 392(4):347-56. PubMed ID: 21194375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tumor-suppressing activity of angiostatin protein resides within kringles 1 to 3.
    MacDonald NJ; Murad AC; Fogler WE; Lu Y; Sim BK
    Biochem Biophys Res Commun; 1999 Oct; 264(2):469-77. PubMed ID: 10529387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanism of action of angiostatin: can you teach an old dog new tricks?
    Moser TL; Stack MS; Wahl ML; Pizzo SV
    Thromb Haemost; 2002 Mar; 87(3):394-401. PubMed ID: 11916069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells.
    Cao Y; Ji RW; Davidson D; Schaller J; Marti D; Söhndel S; McCance SG; O'Reilly MS; Llinás M; Folkman J
    J Biol Chem; 1996 Nov; 271(46):29461-7. PubMed ID: 8910613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiostatin.
    Cao Y; Xue L
    Semin Thromb Hemost; 2004 Feb; 30(1):83-93. PubMed ID: 15034800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. X-ray crystallographic structure of the angiogenesis inhibitor, angiostatin, bound to a peptide from the group A streptococcal surface protein PAM.
    Cnudde SE; Prorok M; Castellino FJ; Geiger JH
    Biochemistry; 2006 Sep; 45(37):11052-60. PubMed ID: 16964966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesis.
    Ji WR; Castellino FJ; Chang Y; Deford ME; Gray H; Villarreal X; Kondri ME; Marti DN; Llinás M; Schaller J; Kramer RA; Trail PA
    FASEB J; 1998 Dec; 12(15):1731-8. PubMed ID: 9837863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of the NG2 proteoglycan to kringle domains modulates the functional properties of angiostatin and plasmin(ogen).
    Goretzki L; Lombardo CR; Stallcup WB
    J Biol Chem; 2000 Sep; 275(37):28625-33. PubMed ID: 10889192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiostatin and angiostatin-related proteins.
    Soff GA
    Cancer Metastasis Rev; 2000; 19(1-2):97-107. PubMed ID: 11191071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth.
    Cao Y; Chen A; An SS; Ji RW; Davidson D; Llinás M
    J Biol Chem; 1997 Sep; 272(36):22924-8. PubMed ID: 9278456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiostatin's molecular mechanism: aspects of specificity and regulation elucidated.
    Wahl ML; Kenan DJ; Gonzalez-Gronow M; Pizzo SV
    J Cell Biochem; 2005 Oct; 96(2):242-61. PubMed ID: 16094651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific interaction of angiostatin with integrin alpha(v)beta(3) in endothelial cells.
    Tarui T; Miles LA; Takada Y
    J Biol Chem; 2001 Oct; 276(43):39562-8. PubMed ID: 11514539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition by kringle 5 of human plasminogen on endothelial cell migration, an important process in angiogenesis.
    Ji WR; Barrientos LG; Llinás M; Gray H; Villarreal X; DeFord ME; Castellino FJ; Kramer RA; Trail PA
    Biochem Biophys Res Commun; 1998 Jun; 247(2):414-9. PubMed ID: 9642142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kringle structures and antiangiogenesis.
    Cao Y; Cao R; Veitonmäki N
    Curr Med Chem Anticancer Agents; 2002 Nov; 2(6):667-81. PubMed ID: 12678719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiostatin and plasminogen share binding to endothelial cell surface actin.
    Dudani AK; Ben-Tchavtchavadze M; Porter S; Tackaberry E
    Biochem Cell Biol; 2005 Feb; 83(1):28-35. PubMed ID: 15746964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The angiogenesis inhibitor protease-activated kringles 1-5 reduces the severity of murine collagen-induced arthritis.
    Sumariwalla PF; Cao Y; Wu HL; Feldmann M; Paleolog EM
    Arthritis Res Ther; 2003; 5(1):R32-9. PubMed ID: 12716451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diurnal variations in angiostatin in human tear fluid: a possible role in prevention of corneal neovascularization.
    Sack RA; Beaton AR; Sathe S
    Curr Eye Res; 1999 Mar; 18(3):186-93. PubMed ID: 10342373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-directed targeting of angiostatin's receptor annexin II inhibits Lewis Lung Carcinoma tumor growth via blocking of plasminogen activation: possible biochemical mechanism of angiostatin's action.
    Sharma MR; Rothman V; Tuszynski GP; Sharma MC
    Exp Mol Pathol; 2006 Oct; 81(2):136-45. PubMed ID: 16643891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.